Key Patent Expirations and Their Impact on the CD-38 Market
The CD-38 forecast anticipates that the market will continue to grow, despite patent expirations. The rise in multiple myeloma cases, as highlighted by CD-38 epidemiology, and the increasing use of combination therapies will sustain demand. Overall, while patent expirations will introduce
